Elmholdt, Tina Rask <br/><br/>
Positive effect of low-dose imatinib mesylate in a patient with nephrogenic systemic fibrosis.  [electronic resource] 

 -  Acta dermato-venereologica  Jun 2011 
 - 478-9 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1651-2057 
<br/><br/><label>Standard No.: </label>10.2340/00015555-1085  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Benzamides<br/>Humans<br/>Imatinib Mesylate<br/>Joints--drug effects<br/>Male<br/>Nephrogenic Fibrosing Dermopathy--diagnosis<br/>Piperazines--administration & dosage<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Range of Motion, Articular<br/>Recovery of Function<br/>Severity of Illness Index<br/>Skin--drug effects<br/>Time Factors<br/>Treatment Outcome